ArticleFrontiers in pharmacology2026
Discovery of potent and highly selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for treating diabetic nephropathy.
Haotian Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.